NephroSync™
A kidney-focused platform in development designed to help teams forecast CKD progression, compare intervention strategies, and make more proactive decisions over time.
Built for the realities of CKD
Chronic kidney disease is not a single straight-line decline. Patients with similar stages or laboratory values can still follow very different paths over time depending on treatment response, hemodynamic changes, acute events, metabolic burden, and competing clinical risks.
That is one reason CKD can be difficult to manage with static tools alone. Stage assignments, isolated measurements, and periodic reassessment remain important, but they do not always show where a patient is heading, whether decline is accelerating, or how a different management strategy might change the course of disease. NephroSync™ is being developed to help address that problem with a more forward-looking and patient-specific approach.
What NephroSync™ does
NephroSync™ is BioTraject Systems’ first flagship product in development. It is designed to use longitudinal clinical data to build a clearer picture of CKD progression in an individual patient. NephroSync™ is being developed to make CKD progression easier to follow, easier to compare across scenarios, and easier to use in structured decision-making.
Its purpose is to help teams move beyond a point-in-time view of disease and toward a more practical understanding of questions such as:
- How is kidney function changing over time?
- Is this patient progressing steadily or becoming unstable?
- What may happen under different treatment or monitoring strategies?
- Which patients may need closer attention sooner?
- confidence-based safeguards for downstream use
Key capabilities
Patient-specific CKD forecasting
NephroSync™ is being developed to estimate how kidney disease may progress in an individual patient over time rather than relying only on broad population averages.
Scenario comparison
The platform is designed to compare possible future paths under different management strategies, helping teams evaluate options before acting.
More structured monitoring decisions
The platform is intended to support more organized thinking around follow-up intensity, monitoring cadence, and when reassessment may matter most.
Confidence-based safeguards
NephroSync™ is also being designed with checks tied to confidence, data quality, and fit so outputs can be used more carefully and responsibly.
Clearer interpretation of changing disease patterns.
NephroSync™ is being developed to help distinguish whether worsening signals appear persistent, temporary, or part of a broader shift in progression.
Intervention Timing Support
NephroSync™ is being developed to help teams assess when a change in management may matter most by identifying points where earlier or more targeted action could alter the projected course.
More than a CKD risk tool
Many existing CKD tools are built to classify, flag, or predict. NephroSync™ is being developed to support something more practical: a structured view of how disease may evolve and how different decisions may alter that path.
More than classification
NephroSync™ is not being developed simply to assign a CKD stage or label a patient as high risk.
More than a one-time prediction
The goal is not only to estimate the chance of an outcome, but to help teams understand how progression may unfold over time.
More than passive analytics
The platform is intended to support active comparison of management options, not just retrospective description of risk.
Who NephroSync™ is for
NephroSync™ is being developed for multiple use settings.
Nephrology programs and kidney care organizations
Support a more proactive view of CKD progression, patient prioritization, and intervention timing.
Biopharma and real-world evidence teams.
Support scenario evaluation and future analytical applications in kidney-focused development programs.
Research collaborators
Provide a computational foundation for CKD modeling, translational research, and structured evaluation of disease progression.
Health systems
Help create a more organized understanding of progression patterns, monitoring needs, and kidney-related clinical complexity.
Why CKD needs this
CKD is shaped by more than declining eGFR alone. Over time, progression reflects the interaction of renal function, hemodynamics, metabolic burden, acute destabilization, treatment exposure, and cardiovascular complexity. That makes CKD difficult to understand through static snapshots alone. There is real value in tools that can help teams see progression earlier, compare future options more clearly, and make decisions with a better view of what may happen next. NephroSync™ is being developed around that need.
Toward more proactive kidney care
NephroSync™ is being developed to help make CKD progression more visible, more understandable, and more actionable. By combining longitudinal clinical data, patient-specific forecasting, and structured scenario comparison, NephroSync™ aims to support a more proactive and informed approach to chronic kidney disease.
NephroSync™ at a glance
1. BioTraject Systems’ first flagship product in development
2. Focused on chronic kidney disease and related complexity
3. Designed to forecast progression over time
4. Built to compare management scenarios before action
5. Intended for healthcare, research, and life sciences use
